C-10386

N/A

Report date: 2023/12/12 17:51:32

Base Information

Drug NameC-10386
Drug Alias NameC-10386C10386
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyrus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A